Mounting evidence reveals that AFP > 1000 ng/mL manifested in HCC patients either within or outside MC portends reduced post-LT survival and considerable risk of HCC recurrence [22,25,26]. This evidence concerns the gene AFP and hepatocellular carcinoma.